Cannabis Law Report

JANUARY 12, 2022

. “Gb Sciences has established a pipeline of patent-protected combination therapies for the treatment of medical conditions affecting hundreds of millions of people,” said Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences. ” Gb Sciences’ intellectual property portfolio includes five U.S.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

NOVEMBER 12, 2021

Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial. In compliance with current Good Manufacturing Practice requirements, the Company delivered ANEB-001’s active pharmaceutical ingredient to its contract manufacturer to fill into 10 mg and 50 mg capsules for finished product.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

NOVEMBER 12, 2021

The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence. OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Law Report

AUGUST 18, 2022

Smith , a partner with the firm and co-leader of the firm’s Life Sciences & Health Effects Team, will lead the practice, bringing together scientist-attorneys and experienced litigators to support clients that are driving innovation in mental health treatments. Tweet this. However, change appears imminent. ” Joining Ms.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

MMJ Recs

DECEMBER 17, 2023

To qualify for the program, patients must have explored other treatment options unsuccessfully and be under the care of a qualified physician. These dispensaries operate under strict regulations to ensure compliance with the TCUP guidelines. Cultivation for personal use or unauthorized purposes is considered a criminal offense.

Law 52

Law Clinical Trials Dispensary Programs 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

DECEMBER 9, 2021

MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

NOVEMBER 29, 2019

Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said. Our main priority is informing national and EU institutions about the opportunity that this treatment is offering,” said Sita Schubert, secretary general of EUMCA.

Medicine 45

Medicine Clinical Trials Treatment Access 45

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. After two years of a global pandemic, mental health conditions are a more urgent need than ever.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 40

Clinical Trials Research and Development Data Medicine 40

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. This is true if patients have the necessary medical conditions and if other treatments have not been effective. When used by humans, CBD shows no possibility of abuse or dependence. Now we come to CBD.

THC 81

THC CBD Legalization Oil 81

Cannabis Law Report

MARCH 21, 2019

Only CBD products produced in compliance with the Farm Bill would be legal by federal law. In order to legally posses CBD in Alabama , you must be in accordance to Leni’s Law which states you must be diagnosed with a debilitating medical condition and be undergoing treatment or you are part of a state-sponsored clinical trial.

State Laws 55

State Laws Law CBD Legalization 55

MMJ Recs

JULY 3, 2024

One potential and alternative treatment for anxiety and stress has emerged over the years. For qualifying patients, staying informed about local regulations through state health department resources and reputable CBD retailers is essential to ensure compliance and safety. Image by Suzy Hazelwood on Pexels.

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

JUNE 1, 2021

Over the course of her career, she has established, developed, and led several key areas of human resource functions including communications and strategy, talent engagement and management, compliance, and mergers and acquisitions. Company remains on track for potential approval of Vicineum™ in the US in August 2021. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. These campaigns focus on dispelling myths, highlighting success stories, and educating the public about the science behind cannabis-based treatments.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Data Business 40

Cannabis Law Report

SEPTEMBER 21, 2021

If we are going to provide medicinal cannabis opportunities covered by insurance, we need the ability to go through clinical trials and testing. Should there be even stricter environmental compliance with on the illegal but also on the “regulated” side of things? In a perfect world, how would you manage this issue? .

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

JUNE 9, 2022

We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

DECEMBER 21, 2019

Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.

Research and Development 45

Research and Development CBD Conditions Therapy 45

Cannabis Law Report

SEPTEMBER 3, 2019

We are dedicated to making our compliance regimen second-to-none in Australia just as it is in Canada,” said Mr. McCutcheon. The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses. Australian Leadership Appointments.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required). The hardest part has already been done.

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

DECEMBER 21, 2021

Facilitating workforce proof of health compliance data, Dalrada Health’s CLIA-certified laboratory provides on-site concierge services and holds national capability. Ignite products are ecologically responsible and do not require additional wastewater treatment. billion in 2019 Q3.

Research and Development 40

Research and Development Supply Chain Data Business 40

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. For the regulated community, this is a trend worth watching.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

JUNE 3, 2022

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

The Cannigma

FEBRUARY 11, 2021

All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I You know, started doing clinical trials through Zelda Therapeutics, and all the other things I’ve done. Elana: So you mentioned the three factors for compliance. I know how to collect data. Elana: Right.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

JANUARY 9, 2019

Now the former finance executive is on a mission to stamp out diabetes in some of the world’s worst-hit areas with a revolutionary marijuana treatment engineered by his firm, Phoenix Life Sciences International. It showed us there were ways to have formulas that were more effective for diabetes, and others for the treatment of cancers.”.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

JULY 24, 2019

321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body. March 25, 2019 posting – “CBD is being adopted more and more as a natural alternative to pharmaceutical-grade treatments for depression and anxiety.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

MARCH 1, 2022

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. ImmunoFlex’s believes that the immune system changes observed in this clinical study are beneficial changes with the potential to improve immune system competence. federal law.

Research and Development 81

Research and Development Clinical Trials Events Treatment 81

Cannabis Law Report

MARCH 29, 2022

With Mike, MAPS PBC is taking another major step in building a world-class pharmaceutical organization capable of meeting the enormous need for novel treatments for PTSD and other mental health conditions. He brings to MAPS PBC a wealth of experience in drug development, expertise in drug commercialization, and a global perspective.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Access 52

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). One such circumstance is a clinical trial. medical practitioner), an organisation (e.g.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

AUGUST 17, 2021

Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis. Medical Imaging Software Improves Diagnostic Accuracy and Supports Doctors in Designing Better Treatment for Patients. Smart Inhalers Enable High Patient Engagement and Improve Treatment Effectiveness.

Research and Development 76

Research and Development Clinical Trials Concentrates Patients 76

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. By passing the Cannabis Act, Canada has taken a position of principled non-compliance with its international drug treaty obligations,” says Fraser.

Law 40

Law Seed-To-Sale Hemp Recreational 40